Evidence map›Paper›PMID 34722679›Full record

ArticleFrontiers in cardiovascular medicine2021

Late Cardiac Pathology in Severe Covid-19. A Postmortem Series of 30 Patients.

Ana Ferrer-Gómez, Héctor Pian-Arias, Irene Carretero-Barrio, Antonia Navarro-Cantero, David Pestaña, Raúl de Pablo, José Luis Zamorano, Juan Carlos Galán, Belén Pérez-Mies, Ignacio Ruz-Caracuel and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. How Does COVID-19 Affect the Heart?Current cardiology reports · 2023
    Review
  4. Article
  5. Risk of Cardiovascular Events After COVID-19.The American journal of cardiology · 2022
    Article
  6. Review
  7. Review
  8. Article
  9. Mitochondria, a Missing Link in COVID-19 Heart Failure and Arrest?Frontiers in cardiovascular medicine · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Ana Ferrer-GómezPathology Department, University Hospital Ramón y Cajal, Madrid, Spain.
Héctor Pian-AriasPathology Department, University Hospital Ramón y Cajal, Madrid, Spain.
Irene Carretero-BarrioPathology Department, University Hospital Ramón y Cajal, Madrid, Spain.
Antonia Navarro-CanteroPathology Department, University Hospital Ramón y Cajal, Madrid, Spain.
David PestañaFaculty of Medicine, Alcalá University, Alcalá de Henares, Spain.
Raúl de PabloFaculty of Medicine, Alcalá University, Alcalá de Henares, Spain.
José Luis ZamoranoFaculty of Medicine, Alcalá University, Alcalá de Henares, Spain.
Juan Carlos GalánInstituto Ramón y Cajal for Health Research (IRYCIS), Madrid, Spain.
Belén Pérez-MiesPathology Department, University Hospital Ramón y Cajal, Madrid, Spain.
Ignacio Ruz-CaracuelPathology Department, University Hospital Ramón y Cajal, Madrid, Spain.
José PalaciosPathology Department, University Hospital Ramón y Cajal, Madrid, Spain.
Hospital Universitario Ramón y Cajal · ESInstituto de Salud Carlos III · ESUniversidad de Alcalá · ESInstituto Ramón y Cajal de Investigación Sanitaria · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The role of SARS-CoV-2 as a direct cause in the cardiac lesions in patients with severe COVID-19 remains to be established. Our objective is to report the pathological findings in cardiac samples of 30 patients who died after a prolonged hospital stay due to Sars-Cov-2 infection. We performed macroscopic, histological and immunohistochemical analysis of the hearts of 30 patients; and detected Sars-Cov-2 RNA by RT-PCR in the cardiac tissue samples. The median age of our cohort was 69.5 years and 76.6% were male. The median time between symptoms onset and death was 36.5 days. The main comorbidities were arterial hypertension (13 patients, 43.3%), dyslipidemia (11 patients, 36.7%), cardiovascular conditions (8 patients, 26.7%), and obesity (8 patients, 26.7%). Cardiovascular conditions included ischemic cardiopathy in 4 patients (13.3%), hypertrophic cardiomyopathy in 2 patients (6.7%) and valve replacement and chronic heart failure in one patient each (3.3%). At autopsy, the most frequent histopathological findings were coronary artery atherosclerosis (8 patients, 26.7%), left ventricular hypertrophy (4 patients, 13.3%), chronic epicardial inflammation (3 patients, 10%) and adipose metaplasia (2 patients, 6.7%). Two patients showed focal myocarditis, one due to invasive aspergillosis. One additional patient showed senile amyloidosis. Sars-Cov-2 RNA was detected in the heart of only one out of 30 patients, who had the shortest disease evolution of the series (9 days). However, no relevant cardiac histological alterations were identified. In present series, cardiac pathology was only modest in most patients with severe COVID-19. At present, the contribution of a direct effect of SARS-CoV-2 on cardiac lesions remains to be established.

Indexed as

autopsycardiac pathologyCOVID-19heartSARS-CoV-2

Identifiers

PMID34722679
PMCPMC8555828
OpenAlexW3206024673

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.